Publications by authors named "G W Vetrovec"

Article Synopsis
  • The Society for Cardiovascular Angiography & Interventions (SCAI) focuses on supporting interventional cardiology professionals and patients through various initiatives.
  • The SCAI Scientific Oversight Committee reviews the scientific needs of its members annually, utilizing survey-based research to understand practice patterns and perspectives.
  • This document serves as a guide for developing relevant surveys, ensures transparency in the survey process, establishes evaluation criteria, and encourages collaboration among SCAI members to enhance the impact of findings within the cardiology community.
View Article and Find Full Text PDF

Lower extremity endovascular intervention (LE-EVI) is gaining popularity as the primary treatment modality for patients with symptomatic peripheral artery disease refractory to noninvasive management. We examined the contemporary patterns of care, regional variation, and outcomes of ambulatory LE-EVI in the United States. The National Ambulatory Surgery Sample was analyzed to identify 266,563 records with peripheral artery disease and LE-EVI between January 1, 2016 and December 31, 2017.

View Article and Find Full Text PDF

Cardiac catheterization laboratory (CCL) morbidity and mortality conferences (MMCs) are a critical component of CCL quality improvement programs and are important for the education of cardiology trainees and the lifelong learning of CCL physicians and team members. Despite their fundamental role in the functioning of the CCL, no consensus exists on how CCL MMCs should identify and select cases for review, how they should be conducted, and how results should be used to improve CCL quality. In addition, medicolegal ramifications of CCL MMCs are not well understood.

View Article and Find Full Text PDF

In patients at high risk for haemodynamic instability during percutaneous coronary intervention (PCI), practitioners are increasingly opting for prophylactic mechanical circulatory support, such as the Impella® heart pump (Abiomed, Danvers, MA, USA). Though Impella-supported high-risk PCI (HRPCI) ensures haemodynamic stability during the PCI procedure, access-related complication rates have varied significantly in published studies. Reported variability in complication rates relates to many factors, including anticoagulation practices, access and closure strategy, post-procedure care and variations in event definitions.

View Article and Find Full Text PDF